Regulatory Affairs
Soligenix Appoints Former White House Economic Advisor Tomas Philipson to Guide Rare Disease Drug Development
Soligenix's appointment of healthcare policy expert Tomas Philipson signals strategic positioning to navigate regulatory pathways for its lead rare disease treatment HyBryte™, potentially accelerating market access for unmet medical needs.
Nutriband Secures FDA Meeting for Abuse-Deterrent Fentanyl Patch Development
Nutriband Inc. has obtained FDA approval for a Type C meeting regarding its AVERSA™ abuse-deterrent fentanyl patch technology, marking a significant regulatory milestone in addressing opioid abuse through transdermal pharmaceutical innovation.
Mission North Expands with Public Affairs Practice to Address Complex Regulatory Challenges
Mission North launches a public affairs practice led by Emily Field to help clients navigate evolving regulatory landscapes and integrate policy communications with corporate and product strategies.
Haypp Group Strengthens U.S. Leadership Team with Key Appointments in Legal and Regulatory Affairs
Haypp Group enhances its U.S. operations by appointing Issa Abuaita as Head of Legal and Laura Leigh Oyler as Vice President of Regulatory Affairs, signaling a strong commitment to regulatory compliance and harm reduction in the nicotine pouch market.
White House Receives Over 10,000 Public Comments on AI Strategy
The U.S. government's Office of Science and Technology Policy has collected extensive public feedback on its upcoming AI development strategy, signaling widespread public and industry interest in artificial intelligence's future.
United Health Products Faces FDA Hurdle in Medical Device Approval Process
United Health Products navigates regulatory challenges while achieving OTCQB market uplisting, signaling potential strategic shifts in its medical technology development efforts.